0001179110-19-001682.txt : 20190208 0001179110-19-001682.hdr.sgml : 20190208 20190208193538 ACCESSION NUMBER: 0001179110-19-001682 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190206 FILED AS OF DATE: 20190208 DATE AS OF CHANGE: 20190208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Myer Vickesh CENTRAL INDEX KEY: 0001742806 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 19581519 MAIL ADDRESS: STREET 1: C/O EDITAS MEDICINE, INC. STREET 2: 11 HURLEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 edgar.xml FORM 4 - X0306 4 2019-02-06 0 0001650664 Editas Medicine, Inc. EDIT 0001742806 Myer Vickesh C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 0 1 0 0 Chief Technology Officer Stock Option (right to buy) 21.10 2019-02-06 4 A 0 48750 0 A 2029-02-05 Common Stock 48750 48750 D Restricted Stock Units 2019-02-06 4 A 0 8125 0 A Common Stock 8125 8125 D This option was granted on February 6, 2019 and is scheduled to vest over four years in equal monthly installments beginning on February 6, 2019 through February 6, 2023. Each restricted stock unit represents the right to receive one share of common stock of Editas Medicine, Inc. The restricted stock unit award is scheduled to vest over four years with 25% of the units vesting on February 6, 2020 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 6, 2023. Shares will be delivered to the Reporting Person when units vest. /s/ Vickesh Myer 2019-02-08